Pediatric melioidosis in Southern India

Related Experiment Video

Updated: Apr 3, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.8K

Chiranjay Mukhopadhyay1, Vandana K Eshwara, Pushpa Kini

  • 1Departments of Microbiology and #Pediatrics, Kasturba Medical College, Manipal University, Manipal Karnataka, India. vandanake@gmail.com.

Indian Pediatrics
|September 22, 2015
PubMed

Insights

Pediatric melioidosis, a bacterial infection, is rising in coastal South India during monsoon season. Early diagnosis and improved lab facilities are crucial for successful treatment and management of this serious childhood illness.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Microbiology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is an emerging infectious disease in tropical regions.
  • Pediatric cases of melioidosis are increasingly reported, particularly in coastal South India during the monsoon.
  • The disease spectrum ranges from localized infections to life-threatening disseminated forms.

Purpose of the Study:

  • To report on a series of 11 pediatric melioidosis cases treated in Southern India.
  • To highlight the clinical presentation, treatment outcomes, and challenges in managing childhood melioidosis.
  • To emphasize the need for increased awareness and enhanced diagnostic capabilities for pediatric melioidosis.

Main Methods:

  • Retrospective case series analysis of 11 children diagnosed with melioidosis.
  • Review of clinical data, treatment regimens, and patient outcomes.
  • Focus on cases identified in the coastal region of Southern India during the monsoon period.

Main Results:

  • Eleven pediatric cases of melioidosis were successfully treated, demonstrating the efficacy of timely intervention.
  • The spectrum of illness varied from localized infections to severe disseminated disease.
  • One mortality was recorded, underscoring the potential severity of the infection.

Conclusions:

  • Pediatric melioidosis is a significant health concern in endemic areas, particularly during the monsoon.
  • Successful treatment outcomes are achievable with prompt diagnosis and appropriate management.
  • There is an urgent need to raise awareness among healthcare professionals and upgrade laboratory infrastructure for accurate and rapid diagnosis of pediatric melioidosis.

More Related Videos

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis07:27

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis

Published on: February 24, 2023

4.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
782
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
745
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
707
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
474
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
335